|
|
 |
|
Total Number of Holdings (excluding cash): 49
| Exact Sciences Corporation |
EXAS |
30063P105 |
1,104 |
$74,089.44 |
3.73% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
3,209 |
$51,804.46 |
2.61% |
| Align Technology, Inc. |
ALGN |
016255101 |
166 |
$50,830.86 |
2.56% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
357 |
$50,392.23 |
2.54% |
| The Cooper Companies, Inc. |
COO |
216648402 |
135 |
$48,845.70 |
2.46% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
1,391 |
$47,725.47 |
2.40% |
| Insulet Corporation |
PODD |
45784P101 |
152 |
$47,560.80 |
2.40% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
183 |
$45,889.08 |
2.31% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
135 |
$45,627.30 |
2.30% |
| BioMerieux |
BIM.FP |
F1149Y232 |
419 |
$44,758.53 |
2.26% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
30 |
$44,889.30 |
2.26% |
| Masimo Corporation |
MASI |
574795100 |
253 |
$44,601.37 |
2.25% |
| Stryker Corporation |
SYK |
863667101 |
160 |
$44,644.80 |
2.25% |
| DENTSPLY SIRONA Inc. |
XRAY |
24906P109 |
1,177 |
$44,396.44 |
2.24% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,263 |
$44,107.30 |
2.22% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
678 |
$43,939.46 |
2.21% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
788 |
$43,599.98 |
2.20% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,549 |
$42,924.22 |
2.16% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
151 |
$42,875.23 |
2.16% |
| Hologic, Inc. |
HOLX |
436440101 |
536 |
$42,451.20 |
2.14% |
| Cochlear Limited |
COH.AU |
Q25953102 |
274 |
$42,039.26 |
2.12% |
| Teleflex Incorporated |
TFX |
879369106 |
171 |
$42,122.43 |
2.12% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
328 |
$41,847.56 |
2.11% |
| Boston Scientific Corporation |
BSX |
101137107 |
838 |
$41,129.04 |
2.07% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,981 |
$41,126.34 |
2.07% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,752 |
$40,269.05 |
2.03% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
85 |
$40,117.45 |
2.02% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
313 |
$39,669.62 |
2.00% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
296 |
$39,548.31 |
1.99% |
| DexCom, Inc. |
DXCM |
252131107 |
344 |
$39,202.24 |
1.98% |
| Alcon Inc. |
ALC.SW |
H01301128 |
574 |
$38,743.52 |
1.95% |
| Steris Plc |
STE |
G8473T100 |
202 |
$37,866.92 |
1.91% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
67 |
$37,195.05 |
1.87% |
| Waters Corporation |
WAT |
941848103 |
123 |
$36,957.81 |
1.86% |
| Becton, Dickinson and Company |
BDX |
075887109 |
149 |
$36,196.57 |
1.82% |
| PerkinElmer, Inc. |
PKI |
714046109 |
279 |
$36,102.60 |
1.82% |
| Agilent Technologies, Inc. |
A |
00846U101 |
267 |
$35,737.95 |
1.80% |
| ResMed Inc. |
RMD |
761152107 |
158 |
$33,736.16 |
1.70% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
102 |
$33,393.07 |
1.68% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
407 |
$33,227.48 |
1.67% |
| Abbott Laboratories |
ABT |
002824100 |
332 |
$32,741.84 |
1.65% |
| Danaher Corporation |
DHR |
235851102 |
132 |
$32,667.36 |
1.65% |
| Medtronic Plc |
MDT |
G5960L103 |
411 |
$32,497.77 |
1.64% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$30,947.94 |
1.56% |
| Terumo Corporation |
4543.JP |
J83173104 |
1,130 |
$29,658.70 |
1.49% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
551 |
$29,461.97 |
1.48% |
| Olympus Corporation |
7733.JP |
J61240107 |
1,640 |
$27,922.76 |
1.41% |
| NovoCure Limited |
NVCR |
G6674U108 |
458 |
$27,035.74 |
1.36% |
| Baxter International Inc. |
BAX |
071813109 |
615 |
$24,932.10 |
1.26% |
| US Dollar |
$USD |
|
4,780 |
$4,780.40 |
0.24% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|